About CareDx
CareDx is a company based in Brisbane (United States) founded in 1998. CareDx has raised $138.21 million across 19 funding rounds from investors including SVB, Intel and Kleiner Perkins. The company has 650 employees as of December 31, 2024. CareDx has completed 9 acquisitions, including Allenex, BFS Molecular and MedActionPlan. CareDx offers products and services including AlloSure, AlloSeq, and AlloCare. CareDx operates in a competitive market with competitors including Tonix Pharma, Eledon, Kedrion, Aditx Therapeutics and Synklino, among others.
- Headquarter Brisbane, United States
- Employees 650 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Caredx, Inc.
-
Annual Revenue
$333.79 M (USD)19.07as on Dec 31, 2024
-
Net Profit
$52.55 M (USD)127.62as on Dec 31, 2024
-
EBITDA
-$33.51 M (USD)59.17as on Dec 31, 2024
-
Total Equity Funding
$138.21 M (USD)
in 19 rounds
-
Latest Funding Round
$15 M (USD), Debt – Conventional
Mar 01, 2018
-
Investors
SVB
& 15 more
-
Employee Count
650
as on Dec 31, 2024
-
Investments & Acquisitions
Allenex
& 8 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CareDx
CareDx is a publicly listed company on the NASDAQ with ticker symbol CDNA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of CareDx
CareDx offers a comprehensive portfolio of products and services, including AlloSure, AlloSeq, and AlloCare.
Monitors kidney transplant health through cfDNA analysis
Facilitates organ matching with advanced genetic testing
App for managing transplant patient medications and health
People of CareDx
Unlock access to complete
Unlock access to complete
Funding Insights of CareDx
CareDx has successfully raised a total of $138.21M across 19 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $15 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CareDx
CareDx has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Intel and Kleiner Perkins.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
Growth stage tech & life sciences focused VC firm funding companies in the US
|
Locked | Locked | Locked |
Investor details for CareDx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CareDx
CareDx has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Allenex, BFS Molecular and MedActionPlan.
Investment portfolio details for CareDx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Organ transplantation management software is provided for healthcare organizations.
|
Locked | Locked | 2020 | Locked | |
|
Developer of diagnostics for post-transplantation care
|
Locked | Locked | 2017 | Locked | |
|
Blood tests for early cancer detection are provided.
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for CareDx
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CareDx
Detailed financials for CareDx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Caredx Comparisons
Peer comparison for CareDx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CareDx
CareDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tonix Pharma, Eledon, Kedrion, Aditx Therapeutics and Synklino, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation medicines for CNS and immunological disorders are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for transplantation in autoimmune and neurodegenerative diseases are developed.
|
|
| Locked | Locked | Locked |
Plasma-derived therapies are developed for hemophilia and immune deficiencies.
|
|
| Locked | Locked | Locked |
Immune monitoring solutions are provided to the medical community.
|
|
| Locked | Locked | Locked |
Drugs for treating chronic viral infections are developed by Synklino.
|
Detailed competitors of CareDx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Caredx
Complete news archive for CareDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CareDx
CareDx was founded in 1998 and raised its 1st funding round 6 years after it was founded.
CareDx is headquartered in Brisbane, United States. It is registered at Brisbane, California, United States.
CareDx is a funded company, having raised a total of $138.21M across 19 funding rounds to date.
As of Dec 31, 2024, the latest employee count at CareDx is 650.
Annual revenue of CareDx is $333.79M as on Dec 31, 2024.
CareDx was founded in 1998 and is headquartered in Brisbane, United States. Precision medicine solutions are offered by the company in the transplant healthcare sector, encompassing products, testing services, and digital tools for pre- and post-transplant care. AlloSure, a non-invasive donor-derived cell-free DNA test, is utilized for detecting kidney injury and rejection in kidney transplant patients. Additional offerings include solutions for heart transplants, laboratory products, and the RemoTraC monitoring service.
CareDx's top competitors include Tonix Pharma, Eledon and Kedrion.
CareDx offers AlloSure, AlloSeq, and AlloCare.
Yes, CareDx is publicly traded on NASDAQ under the ticker symbol CDNA.
CareDx has made 9 acquisitions, including Allenex, BFS Molecular, and MedActionPlan.
CareDx has 16 investors. Key investors include SVB, Intel, Kleiner Perkins, Credit Suisse, and TPG.
The ticker symbol of CareDx is CDNA on NASDAQ.